TRANSLARNA 1000 mg, granulés pour suspension buvable — 30 sachet(s) aluminium

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400927959370
  • CIP7 2795937
  • CIS 68469328
  • Registration number EU/1/13/902

What the source publishes

Holder
PTC THERAPEUTICS INTERNATIONAL (IRLANDE)
Active ingredients
ATALUREN
Form
granulés pour suspension buvable
Package
30 sachet(s) aluminium
Routes
orale
Administrative status
Présentation active
Supply regime
prescription réservée aux spécialistes et services NEUROLOGIE ; prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription hospitalière ; liste I
Marketing status
Arrêt de commercialisation (le médicament n'a plus d'autorisation)
Authorised on
2014-07-31
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400927959370
{
  "cis": "68469328",
  "cip7": "2795937",
  "form": "granulés pour suspension buvable",
  "name": "TRANSLARNA 1000 mg, granulés pour suspension buvable — 30 sachet(s) aluminium",
  "cip13": "3400927959370",
  "holder": "PTC THERAPEUTICS INTERNATIONAL (IRLANDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "PTC THERAPEUTICS INTERNATIONAL (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Alerte",
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2014-07-31",
  "compositions": [
    {
      "name": "ATALUREN",
      "nature": "SA",
      "strength": "1000 mg",
      "linkageNumber": "1",
      "substanceCode": "26023",
      "dosageReference": "un sachet",
      "pharmaceuticalElement": "granulés"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription réservée aux spécialistes et services NEUROLOGIE ; prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription hospitalière ; liste I",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "TRANSLARNA 1000 mg, granulés pour suspension buvable",
  "marketingStatus": "Arrêt de commercialisation (le médicament n'a plus d'autorisation)",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "30 sachet(s) aluminium",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2025-03-28",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ATALUREN"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription réservée aux spécialistes et services NEUROLOGIE",
    "prescription réservée aux spécialistes et services PEDIATRIE",
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription hospitalière",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation archivée",
  "europeanAuthorisationNumber": "EU/1/13/902",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400927959370"